| Heading: |
Medical Treatments |
| Question ID: |
1826521 |
| UIN: |
HL9909 |
| House: |
Lords |
| Date tabled: |
2025-07-24 |
| Asking Member ID: |
2484 |
| Asking Member display name: |
Lord Rennard
|
| Asking Member handle: |
LordRennard
|
| Asking Member Twitter reference: |
@LordRennard
|
| Member interest: |
false |
| Question text: |
To ask His Majesty's Government what assessment they have made of the progress of the National Institute for Health and Care Excellence towards their priorities for 2025–26, including diabetes, and the impact of those priorities on patient access to novel |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-08-04 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
347 |
| Answering Member display name: |
Baroness Merron
|
| Answering Member handle: |
|
| Answering Member Twitter reference: |
Baroness Merron
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The National Institute for Health and Care Excellence (NICE) will shortly be publishing its business plan, which will set out its priorities for 2025/26, following approval by the NICE Board. NICE’s priorities will include delivery of commitments outlined... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |